Craig M. Goodwin

机构：University of North Carolina at Chapel Hill · ORCID：0000-0003-1293-2334

发表论文 189 篇 · 总被引 1803 次 · h-index 16

代表论文

Data from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer (2026 · 被引 1)
Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer (2026 · bioRxiv (Cold Spring Harbor Laboratory))
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition (2026 · PubMed Central)
Figure S3 from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer (2026)
Figure S7 from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer (2026)
Figure S6 from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer (2026)